GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

SMTI · Dec 31, 2023

Sanara MedTech Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001493152-24-011128General Corporate

Debt relative to revenueRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.debt_to_revenue

14.92% · OPTIONAL · NOT_ENOUGH_HISTORY

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.41% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-4.99% · OPTIONAL · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

7.26% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

87.92% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-6.49% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

6.36% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

5.30% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History13 statesHistory building

Jun 30, 20230/7 normalizedLevel 3 Sep 30, 20230/8 normalizedLevel 3 Dec 31, 20230/8 normalizedLevel 3 Mar 31, 20240/8 normalizedLevel 3 Jun 30, 20240/9 normalizedLevel 3 Sep 30, 20240/9 normalizedLevel 3 Dec 31, 20240/9 normalizedLevel 3 Mar 31, 20250/9 normalizedLevel 3 Jun 30, 20257/9 normalizedLevel 3 Sep 30, 20258/9 normalizedLevel 3 Dec 31, 20258/9 normalizedLevel 3 Mar 31, 20268/9 normalizedLevel 3 Jun 30, 20269/9 normalizedLevel 3

Period transition

What moved in the state?

Balance Sheet Leverage Decreased

Previous: 60.47%
Current: 14.92%
Delta: -45.56%

Capex Intensity Decreased

Previous: 1.06%
Current: 0.41%
Delta: -0.65%

Cash Generation Decreased

Previous: 6.64%
Current: -4.99%
Delta: -11.63%

Inventory Pressure Decreased

Previous: 31.33%
Current: 7.26%
Delta: -24.07%

Margin Decreased

Previous: 89.07%
Current: 87.92%
Delta: -1.15%

Profitability Decreased

Previous: -5.66%
Current: -6.49%
Delta: -0.83%

R And D Intensity Increased

Previous: 6.16%
Current: 6.36%
Delta: 0.20%

Sbc Intensity Decreased

Previous: 5.35%
Current: 5.30%
Delta: -0.05%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · SMTI Fundamental State →Has State · Sanara MedTech Inc. →Transitioned To · SMTI Fundamental State →Transitioned To · SMTI BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · SMTI CAPEX_INTENSITY_DECREASED →Transitioned To · SMTI CASH_GENERATION_DECREASED →Transitioned To · SMTI INVENTORY_PRESSURE_DECREASED →Transitioned To · SMTI MARGIN_DECREASED →Transitioned To · SMTI PROFITABILITY_DECREASED →Transitioned To · SMTI R_AND_D_INTENSITY_INCREASED →Transitioned To · SMTI SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.